| 
                        
                            Cestal Cat 80/20 mg
                        
                     | 
                    
                        
                                                            -
                                                    
                     | 
                    
                        
                                                            V/DCP/17/0019
                                                    
                     | 
                    
                        
                                                            Ceva Sante Animale,, Francija
                                                    
                     | 
                    
                        
                                                            QP52AA51
                                                    
                     | 
                    
                        
                                                                                                cats
                                                                                    
                     | 
                    
                                                
                                                            
                                    
                                        Vairāk                                    
                                
                                                    
                     | 
                
                
                    
                        
                            
                                Medicinal product information
                                
                                    
                                        | Pharmaceutical form: | 
                                        
                                                                                                                                                chewable tablets
                                                                                                                                     | 
                                     
                                    
                                        | International name (active substance): | 
                                        
                                                                                            Praziquantel,Pyrantel
                                                                                     | 
                                     
                                    
                                        | Distribution category: | 
                                        
                                                                                                                                                Nonprescription veterinary medicinal product
                                                                                                                                     | 
                                     
                                    
                                        | Manufacturer(s) responsible for batch release | 
                                        
                                                                                            Lavet Pharmaceuticals, Ungārija
                                                                                     | 
                                     
                                    
                                        | Date of authorisation/renewal: | 
                                        
                                                                                            28-Jan-2022
                                                                                     | 
                                     
                                    
                                        | Marketing authorisation valid until: | 
                                        
                                                                                            Unlimited time period
                                                                                     | 
                                     
                                    
                                        | Marketing authorisation procedure: | 
                                        
                                                                                                                                                DCP
                                                                                                                                     | 
                                     
                                    
                                        | Package leaflet: | 
                                        
                                            
                                                                                            
                                                                                                        
                                                    [PDF]                                                    230320LI (23-Mar-2020)                                                
                                                                                     | 
                                     
                                    
                                        | Labelling text: | 
                                        
                                            
                                                                                            
                                                                                                        
                                                    [PDF]                                                    230320M (23-Mar-2020)                                                
                                                                                     | 
                                     
                                    
                                        | Summary of product characteristics: | 
                                        
                                            
                                                                                            
                                                                                                        
                                                    [PDF]                                                    230320ZA (23-Mar-2020)                                                
                                                                                     | 
                                     
                                                                     
                                
                                                                Products
                                
                                    
                                        
                                            | ID | 
                                            Strength | 
                                            Package size | 
                                            Primary packaging | 
                                            
                                            Labelling | 
                                         
                                    
                                    
                                                                                    
                                                | V/DCP/17/0019-01 | 
                                                1 mg | 
                                                1 | 
                                                Al/PE blisteris, 2 tablete | 
                                                
                                                
                                                                                                            -
                                                                                                     | 
                                             
                                                                                    
                                                | V/DCP/17/0019-02 | 
                                                1 mg | 
                                                2 | 
                                                Al/PE blisteris, 2 tablete | 
                                                
                                                
                                                                                                            -
                                                                                                     | 
                                             
                                                                                    
                                                | V/DCP/17/0019-03 | 
                                                1 mg | 
                                                52 | 
                                                Al/PE blisteris, 2 tablete | 
                                                
                                                
                                                                                                            -
                                                                                                     | 
                                             
                                                                                    
                                                | V/DCP/17/0019-04 | 
                                                1 mg | 
                                                1 | 
                                                Al/PE blisteris, 8 tablete | 
                                                
                                                
                                                                                                            -
                                                                                                     | 
                                             
                                                                                    
                                                | V/DCP/17/0019-05 | 
                                                1 mg | 
                                                3 | 
                                                Al/PE blisteris, 8 tablete | 
                                                
                                                
                                                                                                            -
                                                                                                     | 
                                             
                                                                                    
                                                | V/DCP/17/0019-06 | 
                                                1 mg | 
                                                6 | 
                                                Al/PE blisteris, 8 tablete | 
                                                
                                                
                                                                                                            -
                                                                                                     | 
                                             
                                                                                    
                                                | V/DCP/17/0019-07 | 
                                                1 mg | 
                                                13 | 
                                                Al/PE blisteris, 8 tablete | 
                                                
                                                
                                                                                                            -
                                                                                                     | 
                                             
                                                                                    
                                                | V/DCP/17/0019-08 | 
                                                1 mg | 
                                                5 | 
                                                Al/PE blisteris, 2 tablete | 
                                                
                                                
                                                                                                            -
                                                                                                     | 
                                             
                                                                                    
                                                | V/DCP/17/0019-09 | 
                                                1 mg | 
                                                25 | 
                                                Al/PE blisteris, 2 tablete | 
                                                
                                                
                                                                                                            -
                                                                                                     | 
                                             
                                                                            
                                 
                                
                             
                         
                     |